← Back to all trials
Not Yet Recruiting
NCT06900296
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
Conditions: Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: Indiana University
Location: Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana
Summary
This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.
Eligibility Criteria
Inclusion Criteria:
1. ≥ 18 years old at the time of informed consent.
2. Have a diagnosis of cancer and initiating therapy with single agent or combination therapy that includes an immunotherapy (see Appendix 16.1 for list of immunotherapy classes).
3. Ability to provide written informed consent and HIPAA authorization.
Exclusion Criteria:
1\. Not meeting any of the previously described inclusion criteria.
Source: ClinicalTrials.gov (NCT06900296). StuddyBuddy aggregates publicly available trial information.
